Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

Clinical trial NCT05183828 · TERMINATED

Trial details

NCT number: NCT05183828
Sponsor: University of Washington
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Anatomic Stage I Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8 Breast Adenocarcinoma Invasive Breast Carcinoma of No Special Type

Start date: 2022-01-23
Primary completion: 2026-05-13
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.